Ono Pharmaceutical Co., Ltd. (ONO) is inviting you to apply for the 2022 MBC BioLabs Golden Ticket. The company will award one promising start-up company with a year of free lab space (and more!) at MBC BioLabs.
ONO is keen to see emerging innovations in the life science field, which would have potential synergy with its current and future R&D activities.
Here's what you can expect with an ONO - MBC BioLabs Golden Ticket award:
- One-year FREE lab space at MBC BioLabs
- Access to the shared amenities and services provided at MBC BioLabs
- ONO's R&D scientists, business leaders and global network partners
To apply, please submit your non-confidential company presentation at https://mbcbiolabs.com/golden-ticket/ by May 6th.
Once submitted, your company's proposal will be reviewed by ONO's internal committee and finalist companies will be notified and invited to present in end of June. Winners will be notified soon thereafter and presented with awards.
About Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co., Ltd., headquartered in Osaka, is an R&D-oriented pharmaceutical company committed to creating innovative medicines in specific areas. Ono focuses its research on the oncology, immunology, neurology and specialty research with high medical needs as priority areas for discovery and development of innovative medicines. For further information, please visit the company's website at https://www.ono-pharma.com/.